Natural Alternatives International (NASDAQ:NAII) Coverage Initiated by Analysts at StockNews.com

Equities research analysts at StockNews.com started coverage on shares of Natural Alternatives International (NASDAQ:NAII) in a research note issued to investors on Thursday. The brokerage set a “buy” rating on the stock.

Natural Alternatives International Stock Performance

Shares of NASDAQ:NAII opened at $4.21 on Thursday. The company has a market cap of $26.10 million, a P/E ratio of -2.92 and a beta of 0.62. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.50 and a current ratio of 2.56. Natural Alternatives International has a one year low of $4.02 and a one year high of $7.26. The business’s 50-day simple moving average is $4.28 and its 200 day simple moving average is $4.92.

Institutional Investors Weigh In On Natural Alternatives International

An institutional investor recently raised its position in Natural Alternatives International stock. Geode Capital Management LLC lifted its position in Natural Alternatives International, Inc. (NASDAQ:NAII) by 6.9% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 45,062 shares of the company’s stock after acquiring an additional 2,915 shares during the quarter. Geode Capital Management LLC owned 0.73% of Natural Alternatives International worth $258,000 as of its most recent SEC filing. Institutional investors and hedge funds own 32.40% of the company’s stock.

Natural Alternatives International Company Profile

Natural Alternatives International, Inc engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Australia, Asia, Mexico, and Canada. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products.